In a report released today, Ashwani Verma from UBS maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...

Teva Pharmaceuticals, the largest generic drug manufacturer in the U.S., has agreed to pay $450 million to resolve two claims ...

BOSTON, Oct 10 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA), opens new tab has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients ...

Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the ...

In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order ...

Teva agreed to pay $450 million to resolve kickback allegations related to Copaxone and generic drug price-fixing schemes. Since 2017, over $1 billion has been collected from companies accused of ...

Teva Pharmaceuticals TEVA-0.33%decrease; red down pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal ...

BOSTON (Reuters) -Teva Pharmaceutical Industries Ltd has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients' out-of-pocket drug costs as a means ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PARSIPPANY, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of the first and ...

TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label ...